Abstract:Allicin (2-propene-1-sulfinothioic acid S-2-propenyl ester, diallyl thiosulfinate) extracted from garlic, has proven activity against () infection. In recent years, clinical trials have explored its utility as an add-on therapy with variable outcomes reported.To perform a systemic review of allicin as an add-on treatment for infection and assess its efficacy in randomized controlled trials (RCTs).Electronic databases including MEDLINE, EMBASE, the Web of Science, the Cochrane Database, the China National Knowledge Infrastructure Database, Chinese VIP Information Databases, Chinese Medical Databases, and the Wan-Fang Database were searched for keywords including "allicin", "", "randomized clinical trials", and their synonyms. A meta-analysis was performed using the fixed-effects model for low heterogeneity and the random-effects model for high heterogeneity with sensitivity analysis. Bias was evaluated using Egger's tests. Trial sequential analysis (TSA) was used to evaluate information size and treatment benefits. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to assess the level of quality, and studies were classed as "high quality", "moderate quality", "low quality", and "very low quality".A total of eight RCTs consisting of 867 participants (435 from the allicin group and 432 from the control group) were included. Eradication rate in the allicin group (93.33%, 406/435) was significantly higher than that of the control group (83.56%, 361/432) [ = 0%, odds ratio (OR) = 2.75, 95% confidence interval (CI): 1.74-4.35, < 0.001]. The healing rate of ulcers following therapy in the allicin group (86.17%, 349/405) was significantly higher than that of the control group (75.87%, 305/402) [ = 0%, OR = 2.05, 95%CI: 1.39-3.03, < 0.001]. The total remission rate of peptic ulcers across all allicin groups was 97.16%, which was significantly higher than that of controls [96.05% (389/405) 86.55% (360/402), = 0, OR = 3.04, 95%CI: 1.51-6.12, = 0.015]. No significant differences in side effects were observed. TSA suggested that the trials were of sufficient standard to draw reliable conclusions. The quality of outcomes including eradication rates and side effects was graded as "very low" due to downgrades for "risk of bias" and "indirectness". Other outcomes such as ulcer healing rates and total ulcer remission rates were graded as "low" due to downgrades for "risk of bias".Allicin as an add-on therapy improves eradication, healing of ulcers, and remission of symptoms. These results are suggested to be treated with caution due to limited quality.

Therapeutic Hotline. Oral allicin in the treatment of Behcet's disease through attenuating oxidative stress: A pilot study in 20 patients with mucocutaneous lesions

Allicin Decreases Lipopolysaccharide-Induced Oxidative Stress and Inflammation in Human Umbilical Vein Endothelial Cells Through Suppression of Mitochondrial Dysfunction and Activation of Nrf2

Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis

Allicin, an Emerging Treatment for Pulmonary Arterial Hypertension: An Experimental Study

Efficacy and Safety of Low-Dose Interleukin 2 for Behçet’s Syndrome: a Phase 2 Randomized Double-Blind Placebo-Controlled Clinical Trial

Effectiveness and Safety of Chinese Medicine Decoctions for Behcet's Disease: A Systematic Review and Meta-Analysis

Profiling the microbiome of oral and genital mucosal surfaces in Behçet's disease

Allicin and health: A comprehensive review

Antibacterial, Anti-Inflammatory, And Anti-Osteoclastogenesis Roles Of Allicin In Periodontitis

Preliminary study of low-dose photodynamic therapy on the oxidative stress response of Cutibacterium acnes

Characterization of potential salivary biomarkers in Behçet's disease

The Role of Colchicine in Different Clinical Phenotypes of Behcet Disease

Colchicine Modulates Oxidative Stress in Serum and Neutrophil of Patients with Behçet Disease Through Regulation of Ca2+ Release and Antioxidant System

Investigation of the Effects of Allicin on the Nasal Mucosa

Allicin Mitigates Diabetic Retinopathy in Rats by Activating Phosphatase and Tensin Homolog-induced Kinase 1/Parkin-mitophagy and Inhibiting Oxidative Stress-mediated NOD-like Receptor Family Pyrin Domain Containing 3 Inflammasome

Effects of allicin on human Simpson-Golabi-Behmel syndrome cells in mediating browning phenotype

Clinical and biochemical assessment of the effect of topical use of coenzyme Q10 versus topical corticosteroid in management of symptomatic oral lichen planus: randomized controlled clinical trial

Potential Hepatoprotective Effects of Allicin on Carbon Tetrachloride-Induced Acute Liver Injury in Mice by Inhibiting Oxidative Stress, Inflammation, and Apoptosis

A Review of the Cardiovascular Benefits and Antioxidant Properties of Allicin

The effect of colchicine treatment on complete blood cell count-based parameters in patients with Behçet's disease

Allicin Protects Renal Function, Improves Oxidative Stress and Lipid Peroxidation in Rats with Chronic Renal Failure